Navigation Links
MAX Launches "Double HELIX" in Maryland's Biotechnology Corridor
Date:6/4/2013

COLLEGE PARK, M.D., June 4, 2013 /PRNewswire-iReach/ -- MAX Launches "Double HELIX" in Maryland's Biotechnology Corridor

COLLEGE PARK, MD (June 3, 2013) – Mid-Atlantic Crossroads (MAX) announces the launch of Double HELIX (Health, Education, Life Sciences, and Internet eXchange), the new high-performance point of presence (PoP) located at the Institute for Bioscience and Biotechnology Research in Rockville, Maryland. Double HELIX offers high-speed big data transfer services through a 100 Gbps-capable networking infrastructure to the Shady Grove Life Sciences Center and the surrounding research community.

The launch of Double HELIX expands the MAX regional network and further facilitates communication and collaboration between scientific researchers. Specifically, the PoP acts like a highway on-ramp to MAX's advanced research network services, enabling the high-speed transfer of large data sets. Scientists are therefore able to conduct vital genomics and life sciences research more efficiently across the region. Double HELIX is also highly scalable, and its infrastructure is able to support multiple 100 Gbps networking connections, depending on scientist and researcher requirements.

"MAX strives to stay one step ahead of the research community's technological needs, and the launch of Double HELIX achieves this goal," said Tripti Sinha , Executive Director of MAX. "Double HELIX is located in the epicenter of research and innovation in Maryland's biotechnology and life sciences business corridor, and we are excited for the opportunities it will create."

Double HELIX operates using Fujitsu technologies and runs multiple 100 Gbps services to support the MAX dense wavelength division multiplexing regional footprint. MAX relies on this advanced optical technology as the base for its network footprint in Maryland, Virginia, and the District of Columbia.

"The launch of Double HELIX was a major undertaking for MAX, and we are proud to see it come to fruition," said Tom Lehman , Director of Research at MAX. "The growth of MAX's network is driven by the needs of the research and science communities, and Double HELIX will certainly help to meet those needs."

For more information about MAX services, please visit www.maxgigapop.net.

About the Mid-Atlantic Crossroads (MAX)

The Mid-Atlantic Crossroads (MAX) is a multi-state GigaPoP led by the University of Maryland. MAX owns and operates an all-optical, Layer 1 core network that is the foundation for a high-performance infrastructure providing state-of-the-art network technology and services. MAX participants include universities, federal research labs, and other research-focused organizations in the Washington and Baltimore metropolitan areas. MAX serves as a connector and traffic aggregator to the Internet2 national backbone and peers with other major networks. Its mission is to provide cutting-edge network connectivity for its participants, tailored and generic data-transport solutions, and advanced services to accommodate and optimize large data flows, and to facilitate network and application research.

Media Contact: Phyllis Dickerson Johnson , Director of Communications and Marketing, Division of Information Technology, University of Maryland, 301.405.4491, phyllis@umd.edu


'/>"/>
SOURCE Mid-Atlantic Crossroads
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
2. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
3. Puritan Medical Products Launches New Series to Tell Customer Stories
4. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
5. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
6. Elsevier Launches New Open Access Journal: Translational Proteomics
7. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
8. Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
9. AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing
10. CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard
11. Clinovo Launches TechTrainings on CDISC Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... Avomeen & ... The event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann ... MichBio member organization. They provide an opportunity to interact with peers, make new connections ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
Breaking Biology Technology:
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
Breaking Biology News(10 mins):